ADC Therapeutics SA
PYRROLOBENZODIAZEPINE-ANTIBODY CONJUGATES
Last updated:
Abstract:
The present disclosure relates to pyrrolobenzodiazepines (PBDs) having a labile C2 or N10 protecting group in the form of a linker to an antibody.
Status:
Application
Type:
Utility
Filling date:
20 Jul 2021
Issue date:
20 Jan 2022